MBL Webinar
Simulating COVID-19 peptide presentation
Webinar: Simulating COVID-19 peptide presentation using the QuickSwitch™ MHC Platform

Presented by MBL Int.
Date: Tuesday, 13th July, at 06:00 pm (CEST)
Speaker: Join Dr. Yuri Poluektov, Research & Development Scientist
Content
The live webinar will focus on the QuickSwitch™ MHC Platform, how it works and what the advantages are over regular tetramers. This presentation will also cover other interesting topics including:
- MHC Class II QuickSwitch™ Platform vs. the MHC Class I QuickSwitch™ Platform.
- Identify COVID-19 derived peptides that can be presented to the immune system with the MHC Class II QuickSwitch™ Platform.
- Staining human cells with the MHC Class II Tetramers created using the MHC Class II QuickSwitch™ Platform.
>> QuickSwitch™ Tetramer Platform and SARS-CoV-2 Peptides
01.07.2021
Cell Adhesion Molecu...
Key Targets Covered by Biorbyt
Single-Domain Antibo...
Superior staining performance with Biotium MiniMab™
Discovery Research
Transfection solutions from Mirus Bio
ChIP-Exo-Seq
Validated Antibodies from Atlas Antibodies
Targeting RNA Editin...
SignalChem’s ADAR Products
